VanKampen J - Search Results

1

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

Lee BD, Shin JH, VanKampen J, Petrucelli L, West AB, Ko HS, Lee YI, Maguire-Zeiss KA, Bowers WJ, Federoff HJ, Dawson VL, Dawson TM. Lee BD, et al. Among authors: vankampen j. Nat Med. 2010 Sep;16(9):998-1000. doi: 10.1038/nm.2199. Epub 2010 Aug 22. Nat Med. 2010. PMID: 20729864 Free PMC article.

2

Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease.

Van Kampen J, Robertson H, Hagg T, Drobitch R. Van Kampen J, et al. Exp Neurol. 2003 Nov;184(1):521-9. doi: 10.1016/j.expneurol.2003.08.002. Exp Neurol. 2003. PMID: 14637121

3

Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation.

Van Kampen JM, Hagg T, Robertson HA. Van Kampen JM, et al. Eur J Neurosci. 2004 May;19(9):2377-87. doi: 10.1111/j.0953-816X.2004.03342.x. Eur J Neurosci. 2004. PMID: 15128392

4

The BSSG rat model of Parkinson's disease: progressing towards a valid, predictive model of disease.

Van Kampen JM, Robertson HA. Van Kampen JM, et al. EPMA J. 2017 Sep 4;8(3):261-271. doi: 10.1007/s13167-017-0114-6. eCollection 2017 Sep. EPMA J. 2017. PMID: 29021837 Free PMC article. Review.

5

The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease.

Van Kampen JM, Baranowski DC, Robertson HA, Shaw CA, Kay DG. Van Kampen JM, et al. PLoS One. 2015 Oct 6;10(10):e0139694. doi: 10.1371/journal.pone.0139694. eCollection 2015. PLoS One. 2015. PMID: 26439489 Free PMC article.

6

Food restriction enhances peak corticosterone levels, cocaine-induced locomotor activity, and DeltaFosB expression in the nucleus accumbens of the rat.

Stamp JA, Mashoodh R, van Kampen JM, Robertson HA. Stamp JA, et al. Brain Res. 2008 Apr 14;1204:94-101. doi: 10.1016/j.brainres.2008.02.019. Epub 2008 Feb 19. Brain Res. 2008. PMID: 18342839

7

Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease.

Van Kampen JM, Baranowski DB, Shaw CA, Kay DG. Van Kampen JM, et al. Exp Gerontol. 2014 Feb;50:95-105. doi: 10.1016/j.exger.2013.11.012. Epub 2013 Dec 3. Exp Gerontol. 2014. PMID: 24316034

8

Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease.

Van Kampen JM, Baranowski D, Kay DG. Van Kampen JM, et al. PLoS One. 2014 May 7;9(5):e97032. doi: 10.1371/journal.pone.0097032. eCollection 2014. PLoS One. 2014. PMID: 24804730 Free PMC article.

9

Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease.

Van Kampen JM, Kay DG. Van Kampen JM, et al. PLoS One. 2017 Aug 24;12(8):e0182896. doi: 10.1371/journal.pone.0182896. eCollection 2017. PLoS One. 2017. PMID: 28837568 Free PMC article.

10

Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior.

Van Kampen JM, Eckman CB. Van Kampen JM, et al. J Neurosci. 2006 Jul 5;26(27):7272-80. doi: 10.1523/JNEUROSCI.0837-06.2006. J Neurosci. 2006. PMID: 16822985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters